DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Roscher M, Hormann I, Leib O. et al.
Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells.
Oncotarget 2013;
04: 218-230.
We do not assume any responsibility for the contents of the web pages of other providers.